CX3CL1 and Alzheimer disease: Increased release of pro-inflammatory cytokines is observed upon decreased microglial CX3CR1 expression in response to fractalkine/CX3CL1 signaling deficiency, which results in a dramatic reduction in adult neurogenesis in chronic stress (Milior et al., 2016) and in AD (Bachstetter et al., 2015).